Home The Word Brain	My Amedeo FAQ Privacy About
	Hanzi Hunter — ultra-fast Hanzi study All 1,152 characters from the aioLingua manual Abstract • About • The 20 audio files ← aioLingua Chinese Online ← Chinese aioLingua PDF

Dermatology

Free Subscription Articles published in N Engl J Med Retrieve available abstracts of 98 articles: HTML format

Single Articles

November 2025
1. HSU YH, Wang HJ
   Cutaneous Metastases from Breast Carcinoma.
   N Engl J Med. 2025;393:2035.
   PubMed    
   
   
   
2. RISCHIN D, Porceddu S, Day F
   Adjuvant Cemiplimab in Cutaneous Squamous-Cell Carcinoma. Reply.
   N Engl J Med. 2025;393:1965.
   PubMed    
   
   
   
3. KIM D, Babaei N, Wu JJ
   Adjuvant Cemiplimab in Cutaneous Squamous-Cell Carcinoma.
   N Engl J Med. 2025;393:1964-1965.
   PubMed    
   
   
   
4. BISSONNETTE R, Soung J, Hebert AA, Pink AE, et al
   Oral Icotrokinra for Plaque Psoriasis in Adults and Adolescents.
   N Engl J Med. 2025;393:1784-1795.
   PubMed     Abstract available
   
   
   
5. KUNKLER IH, Russell NS, Anderson N, Sainsbury R, et al
   Ten-Year Survival after Postmastectomy Chest-Wall Irradiation in Breast Cancer.
   N Engl J Med. 2025;393:1771-1783.
   PubMed     Abstract available
   
   
   
6. STERN RS
   Oral Psoriasis Therapy - For Whom and at What Cost and Risk?
   N Engl J Med. 2025;393:1854-1855.
   PubMed    
   
   
   October 2025
7. RAHIMOV F, Jacobs BM, Lee JS, Mahi NA, et al
   Common Diseases in Clinical Cohorts - Not Always What They Seem.
   N Engl J Med. 2025;393:1589-1598.
   PubMed     Abstract available
   
   
   
8. CORTES J, Punie K, Barrios C, Hurvitz SA, et al
   Sacituzumab Govitecan in Untreated, Advanced Triple-Negative Breast Cancer.
   N Engl J Med. 2025 Oct 19. doi: 10.1056/NEJMoa2511734.
   PubMed     Abstract available
   
   
   
9. CHAPMAN PB, Wolchok JD
   Changing Role of Adjuvant Therapy in Stage III Melanoma.
   N Engl J Med. 2025 Oct 18. doi: 10.1056/NEJMe2514054.
   PubMed    
   
   
   
10. ASCIERTO PA, Del Vecchio M, Merelli B, Gogas H, et al
    Nivolumab for Resected Stage III or IV Melanoma at 9 Years.
    N Engl J Med. 2025 Oct 18. doi: 10.1056/NEJMoa2504966.
    PubMed     Abstract available
    
    
    September 2025
11. OKADA S, Nishikubo M
    Subcutaneous Panniculitis-like T-Cell Lymphoma.
    N Engl J Med. 2025;393:1117.
    PubMed    
    
    
    
12. PASCH M, Tutein Nolthenius J
    Hutchinson's Sign in Subungual Melanoma In Situ.
    N Engl J Med. 2025;393:e13.
    PubMed    
    
    
    July 2025
13. YE P, Bergerson JRE, Brownell I, Starrett GJ, et al
    Resolution of Squamous-Cell Carcinoma by Restoring T-Cell Receptor Signaling.
    N Engl J Med. 2025;393:469-478.
    PubMed     Abstract available
    
    
    June 2025
14. CONLON M, McBee K
    Cutaneous Extramedullary Plasmacytoma after Bone Fracture.
    N Engl J Med. 2025;392:e56.
    PubMed    
    
    
    
15. SRINIVASAN R, Gurram S, Singer EA, Sidana A, et al
    Bevacizumab and Erlotinib in Hereditary and Sporadic Papillary Kidney Cancer.
    N Engl J Med. 2025;392:2346-2356.
    PubMed     Abstract available
    
    
    
16. KU SC, Chiang YY
    Generalized Pustular Psoriasis.
    N Engl J Med. 2025;392:2367.
    PubMed    
    
    
    
17. MAMOUNAS EP, Bandos H, White JR, Julian TB, et al
    Omitting Regional Nodal Irradiation after Response to Neoadjuvant Chemotherapy.
    N Engl J Med. 2025;392:2113-2124.
    PubMed     Abstract available
    
    
    
18. CARDOSO F, Parke S, Brennan DJ, Briggs P, et al
    Elinzanetant for Vasomotor Symptoms from Endocrine Therapy for Breast Cancer.
    N Engl J Med. 2025 Jun 2. doi: 10.1056/NEJMoa2415566.
    PubMed     Abstract available
    
    
    
19. BIDARD FC, Mayer EL, Park YH, Janni W, et al
    First-Line Camizestrant for Emerging ESR1-Mutated Advanced Breast Cancer.
    N Engl J Med. 2025 Jun 1. doi: 10.1056/NEJMoa2502929.
    PubMed     Abstract available
    
    
    May 2025
20. RISCHIN D, Porceddu S, Day F, Brungs DP, et al
    Adjuvant Cemiplimab or Placebo in High-Risk Cutaneous Squamous-Cell Carcinoma.
    N Engl J Med. 2025 May 31. doi: 10.1056/NEJMoa2502449.
    PubMed     Abstract available
    
    
    
21. JHAVERI KL, Im SA, Saura C, Loibl S, et al
    Overall Survival with Inavolisib in PIK3CA-Mutated Advanced Breast Cancer.
    N Engl J Med. 2025 May 31. doi: 10.1056/NEJMoa2501796.
    PubMed     Abstract available
    
    
    
22. CAMPONE M, De Laurentiis M, Jhaveri K, Hu X, et al
    Vepdegestrant, a PROTAC Estrogen Receptor Degrader, in Advanced Breast Cancer.
    N Engl J Med. 2025 May 31. doi: 10.1056/NEJMoa2505725.
    PubMed     Abstract available
    
    
    April 2025
23. DUBE U, Eichenfield D
    Cutaneous Leishmaniasis.
    N Engl J Med. 2025;392:e41.
    PubMed    
    
    
    
24. CHALMERS JD, Burgel PR, Daley CL, De Soyza A, et al
    Phase 3 Trial of the DPP-1 Inhibitor Brensocatib in Bronchiectasis.
    N Engl J Med. 2025;392:1569-1581.
    PubMed     Abstract available
    
    
    
25. BLOCKMANS D, Penn SK, Setty AR, Schmidt WA, et al
    A Phase 3 Trial of Upadacitinib for Giant-Cell Arteritis.
    N Engl J Med. 2025 Apr 2. doi: 10.1056/NEJMoa2413449.
    PubMed     Abstract available
    
    
    March 2025
26. WOLCHOK JD, Hodi FS, Larkin J
    Nivolumab plus Ipilimumab in Advanced Melanoma. Reply.
    N Engl J Med. 2025;392:1246.
    PubMed    
    
    
    
27. SANTHOSH A
    Nivolumab plus Ipilimumab in Advanced Melanoma.
    N Engl J Med. 2025;392:1245-1246.
    PubMed    
    
    
    
28. PANDYA A, Horissian M
    Linear IgA Bullous Dermatosis of Childhood.
    N Engl J Med. 2025;392:1120.
    PubMed    
    
    
    
29. REGINA J, Waeber G
    Thin Skin in Cushing's Syndrome.
    N Engl J Med. 2025;392:e28.
    PubMed    
    
    
    
30. METZ M, Gimenez-Arnau A, Hide M, Lebwohl M, et al
    Remibrutinib in Chronic Spontaneous Urticaria.
    N Engl J Med. 2025;392:984-994.
    PubMed     Abstract available
    
    
    February 2025
31. TRUONG A, Martin S
    Cutaneous Larva Migrans.
    N Engl J Med. 2025;392:e22.
    PubMed    
    
    
    
32. STARNES JR, Welch W, Henderson CC, Hudson S, et al
    Pulse Oximetry and Skin Tone in Children.
    N Engl J Med. 2025 Feb 12. doi: 10.1056/NEJMc2414937.
    PubMed    
    
    
    January 2025
33. COHN DM, Gurugama P, Magerl M, Katelaris CH, et al
    CRISPR-Based Therapy for Hereditary Angioedema.
    N Engl J Med. 2025;392:458-467.
    PubMed     Abstract available
    
    
    
34. EIKA F, Al-Saad S
    Endobronchial Kaposi's Sarcoma.
    N Engl J Med. 2025;392:e15.
    PubMed    
    
    
    
35. GEYER CE JR, Untch M, Huang CS, Mano MS, et al
    Survival with Trastuzumab Emtansine in Residual HER2-Positive Breast Cancer.
    N Engl J Med. 2025;392:249-257.
    PubMed     Abstract available
    
    
    
36. CURTI BD
    Checkpoint Immunotherapy for Melanoma - Offering Hope for Cure.
    N Engl J Med. 2025;392:81-82.
    PubMed    
    
    
    December 2024
37. REIMER T, Stachs A, Veselinovic K, Kuhn T, et al
    Axillary Surgery in Breast Cancer - Primary Results of the INSEMA Trial.
    N Engl J Med. 2024 Dec 12. doi: 10.1056/NEJMoa2412063.
    PubMed     Abstract available
    
    
    
38. JHAVERI KL, Neven P, Casalnuovo ML, Kim SB, et al
    Imlunestrant with or without Abemaciclib in Advanced Breast Cancer.
    N Engl J Med. 2024 Dec 11. doi: 10.1056/NEJMoa2410858.
    PubMed     Abstract available
    
    
    October 2024
39. TURNER NC, Im SA, Saura C, Juric D, et al
    Inavolisib-Based Therapy in PIK3CA-Mutated Advanced Breast Cancer.
    N Engl J Med. 2024;391:1584-1596.
    PubMed     Abstract available
    
    
    
40. MEROLA JF, Kwan MC, Kroshinsky D
    Case 22-2024: A Woman with Postpartum Fever, Abdominal Pain, and Skin Ulcers. Reply.
    N Engl J Med. 2024;391:1663.
    PubMed    
    
    
    
41. PARPERIS K
    Case 22-2024: A Woman with Postpartum Fever, Abdominal Pain, and Skin Ulcers.
    N Engl J Med. 2024;391:1663.
    PubMed    
    
    
    
42. HU HH, Li JH
    Acne Fulminans.
    N Engl J Med. 2024;391:1440.
    PubMed    
    
    
    
43. CHANTRAPITAK J, Chuamanochan M
    Intertriginous Rash in Secondary Syphilis.
    N Engl J Med. 2024;391:e28.
    PubMed    
    
    
    September 2024
44. EIGER D, Vaidya A, Hanberg J, Clark R, et al
    Avoiding Rash Decisions.
    N Engl J Med. 2024;391:e25.
    PubMed    
    
    
    
45. RUSSO G, Alipour Tehrany Y
    Discoid Lupus Erythematosus.
    N Engl J Med. 2024;391:e24.
    PubMed    
    
    
    
46. AL-SAMKARI H, Kasthuri RS, Iyer VN, Pishko AM, et al
    Pomalidomide for Epistaxis in Hereditary Hemorrhagic Telangiectasia.
    N Engl J Med. 2024;391:1015-1027.
    PubMed     Abstract available
    
    
    
47. RUBIN EJ, Yeku OO, Morrissey S
    NEJM at ESMO - Final, 10-Year Outcomes with Nivolumab plus Ipilimumab in Advanced Melanoma.
    N Engl J Med. 2024 Sep 15. doi: 10.1056/NEJMe2411489.
    PubMed    
    
    
    
48. WOLCHOK JD, Chiarion-Sileni V, Rutkowski P, Cowey CL, et al
    Final, 10-Year Outcomes with Nivolumab plus Ipilimumab in Advanced Melanoma.
    N Engl J Med. 2024 Sep 15. doi: 10.1056/NEJMoa2407417.
    PubMed     Abstract available
    
    
    
49. SCHMID P, Cortes J, Dent R, McArthur H, et al
    Overall Survival with Pembrolizumab in Early-Stage Triple-Negative Breast Cancer.
    N Engl J Med. 2024 Sep 15. doi: 10.1056/NEJMoa2409932.
    PubMed     Abstract available
    
    
    
50. BARDIA A, Hu X, Dent R, Yonemori K, et al
    Trastuzumab Deruxtecan after Endocrine Therapy in Metastatic Breast Cancer.
    N Engl J Med. 2024 Sep 15. doi: 10.1056/NEJMoa2407086.
    PubMed     Abstract available
    
    
    
51. YANG J, Liu W
    Angioedema of the Intestines.
    N Engl J Med. 2024;391:941.
    PubMed    
    
    
    
52. HUANG TR, Lee JC
    Gustatory Hyperhidrosis after Parotid Surgery.
    N Engl J Med. 2024;391:e21.
    PubMed    
    
    
    
53. CLAUDIO-OLIVA A, Duran-Romero AJ
    Primary Cutaneous Herpes Simplex Virus Infection of the Cheek.
    N Engl J Med. 2024;391:e20.
    PubMed    
    
    
    August 2024
54. WANDER SA, Thai JN, Wirth LJ, Soto DE, et al
    Case 26-2024: A 59-Year-Old Woman with Aphasia, Anemia, and a Breast Mass.
    N Engl J Med. 2024;391:747-757.
    PubMed    
    
    
    
55. MAKARY N, Razali Q
    Diabetes-Associated Scleredema.
    N Engl J Med. 2024;391:e15.
    PubMed    
    
    
    July 2024
56. WANG WY, Lin MC
    Chilblain Lupus Erythematosus.
    N Engl J Med. 2024;391:e6.
    PubMed    
    
    
    
57. WANG X
    Black Dot Tinea Capitis.
    N Engl J Med. 2024;391:e7.
    PubMed    
    
    
    
58. MEROLA JF, Cochran RL, Kroshinsky D, Prabhu M, et al
    Case 22-2024: A 30-Year-Old Woman with Postpartum Fever, Abdominal Pain, and Skin Ulcers.
    N Engl J Med. 2024;391:260-271.
    PubMed    
    
    
    
59. KOURNOUTAS I, Tung EE
    Yellow Nail Syndrome.
    N Engl J Med. 2024;391:68.
    PubMed    
    
    
    
60. PETERS NE, Mac Lochlainn DJ, Dhalla F, Howarth L, et al
    Normalization of C1 Inhibitor in a Patient with Hereditary Angioedema.
    N Engl J Med. 2024;391:56-59.
    PubMed     Abstract available
    
    
    
61. RIEDL MA, Farkas H, Aygoren-Pursun E, Psarros F, et al
    Oral Sebetralstat for On-Demand Treatment of Hereditary Angioedema Attacks.
    N Engl J Med. 2024;391:32-43.
    PubMed     Abstract available
    
    
    
62. AMERATUNGA R, Longhurst HJ
    New Therapies for Type 1 and Type 2 Hereditary Angioedema.
    N Engl J Med. 2024;391:79-81.
    PubMed    
    
    
    
63. RIEDL MA, Tachdjian R, Lumry WR, Craig T, et al
    Efficacy and Safety of Donidalorsen for Hereditary Angioedema.
    N Engl J Med. 2024;391:21-31.
    PubMed     Abstract available
    
    
    June 2024
64. PLOTKIN SR, Yohay KH, Nghiemphu PL, Dinh CT, et al
    Brigatinib in NF2-Related Schwannomatosis with Progressive Tumors.
    N Engl J Med. 2024;390:2284-2294.
    PubMed     Abstract available
    
    
    
65. SLAMON D, Yardley DA, Hortobagyi G
    Ribociclib plus Endocrine Therapy in Early Breast Cancer. Reply.
    N Engl J Med. 2024;390:2221-2222.
    PubMed    
    
    
    
66. TANNOCK IF, Meirson T, Fojo A
    Ribociclib plus Endocrine Therapy in Early Breast Cancer.
    N Engl J Med. 2024;390:2220-2221.
    PubMed    
    
    
    
67. LI Q, Cai Y, Li J
    Ribociclib plus Endocrine Therapy in Early Breast Cancer.
    N Engl J Med. 2024;390:2220.
    PubMed    
    
    
    
68. TU H, Zhang Y, You Z
    Ribociclib plus Endocrine Therapy in Early Breast Cancer.
    N Engl J Med. 2024;390:2219-2220.
    PubMed    
    
    
    
69. JORGE AM, Ard KL, Turbett SE
    Case 19-2024: A 46-Year-Old Man with Arthritis and Rash.
    N Engl J Med. 2024;390:2200-2207.
    PubMed    
    
    
    
70. ROY N, Mandal M
    Insulin-Induced Lipohypertrophy.
    N Engl J Med. 2024;390:e60.
    PubMed    
    
    
    
71. LONG GV, Hauschild A, Santinami M, Kirkwood JM, et al
    Final Results for Adjuvant Dabrafenib plus Trametinib in Stage III Melanoma.
    N Engl J Med. 2024 Jun 19. doi: 10.1056/NEJMoa2404139.
    PubMed     Abstract available
    
    
    
72. WANG J, Liu J
    Tuberculosis Verrucosa Cutis.
    N Engl J Med. 2024;390:e58.
    PubMed    
    
    
    
73. MIDANI L, Ridgeway G, Phillips CM, Smidt AC, et al
    Inclusive Dermatology - Creating a Diverse Visual Atlas of Skin Conditions.
    N Engl J Med. 2024;390:2037-2038.
    PubMed    
    
    
    
74. VIDULA N, Rodriguez K, Wong AK, Boyraz B, et al
    Case 17-2024: A 45-Year-Old Woman with Metastatic Breast Cancer.
    N Engl J Med. 2024;390:2011-2022.
    PubMed    
    
    
    
75. BLANK CU, Lucas MW, Scolyer RA, van de Wiel BA, et al
    Neoadjuvant Nivolumab and Ipilimumab in Resectable Stage III Melanoma.
    N Engl J Med. 2024 Jun 2. doi: 10.1056/NEJMoa2402604.
    PubMed     Abstract available
    
    
    May 2024
76. WECHSLER ME, Fan Y, Merkel PA
    Benralizumab versus Mepolizumab for Eosinophilic Granulomatosis with Polyangiitis. Reply.
    N Engl J Med. 2024;390:1940.
    PubMed    
    
    
    
77. SUN R, Wei LJ
    Benralizumab versus Mepolizumab for Eosinophilic Granulomatosis with Polyangiitis.
    N Engl J Med. 2024;390:1939.
    PubMed    
    
    
    
78. DASKALAKIS DC, Heller HM, Shenoy ES, Hsu K, et al
    Case 16-2024: A 20-Year-Old Man with a Pustular Rash.
    N Engl J Med. 2024;390:1906-1912.
    PubMed    
    
    
    
79. KOWDLEY KV, Levy C, Jones D
    Phase 3 Trials of Elafibranor and Seladelpar for Primary Biliary Cholangitis. Reply.
    N Engl J Med. 2024;390:1935-1936.
    PubMed    
    
    
    
80. HIRSCHFIELD GM, Kremer AE, Levy C
    Phase 3 Trials of Elafibranor and Seladelpar for Primary Biliary Cholangitis. Reply.
    N Engl J Med. 2024;390:1934-1935.
    PubMed    
    
    
    
81. IJICHI H
    Phase 3 Trials of Elafibranor and Seladelpar for Primary Biliary Cholangitis.
    N Engl J Med. 2024;390:1934.
    PubMed    
    
    
    
82. AREVALO-CANAS C, Arevalo-Serrano J
    Phase 3 Trials of Elafibranor and Seladelpar for Primary Biliary Cholangitis.
    N Engl J Med. 2024;390:1933-1934.
    PubMed    
    
    
    
83. CHEN ST, Cochran RL, Jain S, Stagner AM, et al
    Case 15-2024: A 73-Year-Old Woman with Worsening Rash.
    N Engl J Med. 2024;390:1803-1813.
    PubMed    
    
    
    
84. FEINSTEIN JA
    Learning to Say Goodbye.
    N Engl J Med. 2024;390:1742-1743.
    PubMed    
    
    
    
85. SAADOUN D, Bodaghi B, Cacoub P
    Behcet's Syndrome. Reply.
    N Engl J Med. 2024;390:1731-1732.
    PubMed    
    
    
    
86. IZZEDINE H, Jhaveri KD
    Behcet's Syndrome.
    N Engl J Med. 2024;390:1731.
    PubMed    
    
    
    
87. PAMUK ON
    Behcet's Syndrome.
    N Engl J Med. 2024;390:1730.
    PubMed    
    
    
    
88. FAMULARO G, Bracci M
    Behcet's Syndrome.
    N Engl J Med. 2024;390:1730.
    PubMed    
    
    
    
89. AOKI K, Kojima M
    Polyarteritis Nodosa.
    N Engl J Med. 2024;390:1711.
    PubMed    
    
    
    April 2024
90. SPRAGUE S, O'Hara NN, Slobogean G
    Skin Antisepsis before Surgical Fracture Fixation. Reply.
    N Engl J Med. 2024;390:1533.
    PubMed    
    
    
    
91. SMOLLE MA, Puchwein P, Sadoghi P
    Skin Antisepsis before Surgical Fracture Fixation.
    N Engl J Med. 2024;390:1532-1533.
    PubMed    
    
    
    
92. YIN H, Lu L
    Evolution of Pyoderma Gangrenosum.
    N Engl J Med. 2024;390:e36.
    PubMed    
    
    
    
93. MARIN-ESTEBAN V, Molet L, Lagana M, Ciocan D, et al
    CXCR4 Antagonist in HPV5-Associated Perianal Squamous-Cell Carcinoma.
    N Engl J Med. 2024;390:1339-1341.
    PubMed    
    
    
    
94. DE BONIFACE J, Filtenborg Tvedskov T, Ryden L, Szulkin R, et al
    Omitting Axillary Dissection in Breast Cancer with Sentinel-Node Metastases.
    N Engl J Med. 2024;390:1163-1175.
    PubMed     Abstract available
    
    
    
95. MCGUIRE KP
    Axillary Dissection - The Bell Tolls for Thee.
    N Engl J Med. 2024;390:1231-1232.
    PubMed    
    
    
    March 2024
96. SLAMON D, Lipatov O, Nowecki Z, McAndrew N, et al
    Ribociclib plus Endocrine Therapy in Early Breast Cancer.
    N Engl J Med. 2024;390:1080-1091.
    PubMed     Abstract available
    
    
    
97. WECHSLER ME, Nair P, Terrier B, Walz B, et al
    Benralizumab versus Mepolizumab for Eosinophilic Granulomatosis with Polyangiitis.
    N Engl J Med. 2024;390:911-921.
    PubMed     Abstract available
    
    
    February 2024
98. HIRSCHFIELD GM, Bowlus CL, Mayo MJ, Kremer AE, et al
    A Phase 3 Trial of Seladelpar in Primary Biliary Cholangitis.
    N Engl J Med. 2024;390:783-794.
    PubMed     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Dermatology is free of charge.